Skip to main content

Archana Shanker and Nupur Maithani consider what the battle over the Valcyte patent reveals about the Indian judiciary’s approach to pharmaceutical patents.

The Valcyte patent has followed a rather meandering course at the Indian Patent Office at Chennai. Roche filed Indian parent application 959/MAS/1995 claiming the L­valyl ester of ganciclovir on July 27 1995. The claimed mono-L-valyl ester has the advantage of increased oral bioavailability as compared to the base compound ganciclovir and its L-valyl di- ester. A pre-grant opposition was filed against Roche’s Valcyte application by the Indian Network for People Living with HIV/AIDS (INP+) and the Tamil Nadu Network of People with HIV/AIDS (TNNP+). The opposition was taken on record and Roche was directed to file a statement in reply. Its problems began when, after considering the opposition and reply statement, the Controller of Parents granted a patent (IN 207232) on the Valcyte application without hearing the parties to the opposition.

This article was published in IP Focus: Life Sciences 2010.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates
Aug 25, 2025

At the FICCI–ICRIER Conference on SEPs (23rd August 2025), our Managing Partner Mr. Pravin Anand shared his vision on how India can evolve from being

Conference on Standard Essential Patents (SEPs)
News & Updates
Aug 24, 2025

‘Intellectual Property for a company/ creator is as critical and important as human rights for an individual,’ this guiding belief at ANAND AND ANAND

IAM Strategy 300
Thought Leadership
Aug 21, 2025

‘First published on IAM’ By:  Vaishali R Mittal Patent examination by the Indian Patent Office (IPO) has slowed down dramatically over the last few

Patent examination slowdown risks harming India’s IP momentum
Thought Leadership
Jul 28, 2025

‘First published on Asia IP’ By: Pravin Anand In the book What is Life, written in 1944 by theoretical physicist Erwin Schrödinger, the author states: “A

Human versus machine consciousness